Riskpilot← Back to searchSign inGet full accessFAYE PHYSIOTHERAPY AS
ASActiveOrg 912256383Granstuveien 11F, 1185 OsloPhysiotherapy activities · NACE 8695Est. 20132 employees
Revenue 2024
NOK 1,7M
-14% vs 2023
EBITDA margin
-11.0%
-173% vs 2023
Equity ratio
8.4%
Financial strength
Net profit 2024
NOK -193K
-195% vs 2023
| Revenue | NOK 1,7M | -14% |
| EBITDA | NOK -191K | -173% |
| Net profit | NOK -193K | -195% |
| Total assets | NOK 381K | -21% |
| Equity | NOK 32K | -86% |
| Employees | 2 | — |
Legal name
FAYE PHYSIOTHERAPY AS
Org number
912256383
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
6. august 2013
Share capital
NOK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Fysioterapi og andre tjenester/produkter som naturlig faller sammen med dette, herunder kurs og foredrag, å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender.
Address
Granstuveien 11F, 1185 Oslo
Email
info@fayepattison.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 271 | 1 269 | 1 861 | 2 010 | 1 734 |
| Staff expenses | −1 132 | −899 | −1 418 | −1 349 | −1 576 |
| EBITDA | −54 | 36 | 36 | 261 | −191 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −54 | 36 | 36 | 261 | −191 |
| Net financials | −0 | −119 | −0 | −0 | −1 |
| Profit before tax | −54 | −83 | 36 | 261 | −193 |
| Tax | 0 | −0 | 4 | 58 | −0 |
| Net profit | −54 | −83 | 32 | 203 | −193 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 318 | 153 | 303 | 482 | 381 |
| Equity | 73 | −10 | 21 | 225 | 32 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 246 | 163 | 282 | 257 | 349 |
| Total debt | 246 | 163 | 282 | 257 | 349 |
EBITDA margin
-11.0%
This company
15.8%
Market median
-170% vs market
20202024
Equity ratio
8.4%
This company
38.2%
Market median
-78% vs market
20202024
Return on equity
-600.5%
This company
18.4%
Market median
-3364% vs market
20202024
Net profit margin
-11.1%
This company
8.1%
Market median
-237% vs market
20202024
Asset turnover
4.55×
This company
1.12×
Market median
+306% vs market
20202024
Debt / equity
10.89×
This company
0.62×
Market median
-1656% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CF Chief Executive Officer | Chief Executive Officer | 2013 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FAYE PHYSIOTHERAPY AS 
LØRENSKOG FYSIOTERAPI OG OSTEOPATI ASBoard members of FAYE PHYSIOTHERAPY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Faye-Schjøll | Chief Executive Officer | 0 companies |